# Nanomosaic and BMS Investigate Nanoneedle Technology to Improve AAV Manufacturing Process
## Main Ideas and Facts:
– Nanomosaic and Bristol Myers Squibb conducted a study based on a white paper.
– The study showed that nanoneedle technology is successful in quantifying AAV subpopulations.
– This technology provides valuable insights for enhancing the production of full-length vectors.
### Author’s Take:
Nanomosaic and Bristol Myers Squibb’s collaborative study outlines the potential of nanoneedle technology in advancing the AAV manufacturing process. This innovative approach could revolutionize the way AAV subpopulations are quantified, ultimately leading to improved production efficiency and quality control.
Click here for the original article.